CME Group Inc (CME) Position Maintained by Baldwin Brothers Inc. MA

Baldwin Brothers Inc. MA held its stake in CME Group Inc (NASDAQ:CME) during the first quarter, according to its most recent 13F filing with the SEC. The fund owned 913 shares of the financial services provider’s stock at the end of the first quarter. Baldwin Brothers Inc. MA’s holdings in CME Group were worth $108,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of the company. Hudock Capital Group LLC raised its position in shares of CME Group by 0.5% in the third quarter. Hudock Capital Group LLC now owns 3,726 shares of the financial services provider’s stock valued at $389,000 after buying an additional 20 shares in the last quarter. Investec Asset Management PTY Ltd raised its position in shares of CME Group by 0.3% in the fourth quarter. Investec Asset Management PTY Ltd now owns 7,790 shares of the financial services provider’s stock valued at $900,000 after buying an additional 26 shares in the last quarter. Johnson Financial Group Inc. raised its stake in CME Group by 5.9% in the fourth quarter. Johnson Financial Group Inc. now owns 899 shares of the financial services provider’s stock worth $104,000 after buying an additional 50 shares during the period. Pekin Singer Strauss Asset Management IL raised its stake in CME Group by 0.5% in the third quarter. Pekin Singer Strauss Asset Management IL now owns 13,875 shares of the financial services provider’s stock worth $1,450,000 after buying an additional 64 shares during the period. Finally, CENTRAL TRUST Co raised its stake in CME Group by 0.5% in the third quarter. CENTRAL TRUST Co now owns 16,132 shares of the financial services provider’s stock worth $1,686,000 after buying an additional 76 shares during the period. Hedge funds and other institutional investors own 80.06% of the company’s stock.

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

CME Group Inc (NASDAQ:CME) traded up 0.92% on Friday, hitting $116.83. 2,711,520 shares of the company were exchanged. The firm has a 50 day moving average of $117.43 and a 200-day moving average of $118.03. The stock has a market cap of $39.70 billion, a PE ratio of 25.29 and a beta of 0.88. CME Group Inc has a 52-week low of $92.29 and a 52-week high of $127.60.

CME Group (NASDAQ:CME) last posted its earnings results on Thursday, April 27th. The financial services provider reported $1.22 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $1.20 by $0.02. CME Group had a return on equity of 7.28% and a net margin of 42.67%. The business had revenue of $929 million during the quarter, compared to analysts’ expectations of $932.06 million. During the same period in the previous year, the business earned $1.15 earnings per share. The firm’s revenue was down .5% on a year-over-year basis. On average, equities analysts expect that CME Group Inc will post $4.88 earnings per share for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “CME Group Inc (CME) Position Maintained by Baldwin Brothers Inc. MA” was originally published by BBNS and is the sole property of of BBNS. If you are reading this news story on another publication, it was stolen and reposted in violation of international trademark and copyright legislation. The correct version of this news story can be read at https://baseballnewssource.com/markets/baldwin-brothers-inc-ma-maintains-position-in-cme-group-inc-cme-updated-updated-updated/635396.html.

A number of equities research analysts have issued reports on CME shares. JPMorgan Chase & Co. lowered shares of CME Group from an “overweight” rating to a “neutral” rating in a report on Tuesday, January 31st. Zacks Investment Research lowered shares of CME Group from a “buy” rating to a “hold” rating in a report on Wednesday, February 8th. Jefferies Group LLC reiterated a “buy” rating and set a $128.00 target price on shares of CME Group in a report on Saturday, March 11th. Royal Bank of Canada restated an “outperform” rating and issued a $134.00 price objective on shares of CME Group in a report on Thursday, March 30th. Finally, Deutsche Bank AG reduced their price objective on shares of CME Group from $139.00 to $136.00 and set a “buy” rating on the stock in a report on Thursday, April 6th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $114.33.

In related news, insider Hilda Harris Piell sold 3,043 shares of the business’s stock in a transaction dated Tuesday, March 14th. The stock was sold at an average price of $124.26, for a total transaction of $378,123.18. Following the completion of the transaction, the insider now directly owns 26,082 shares in the company, valued at $3,240,949.32. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, Director Dennis Suskind sold 1,099 shares of CME Group stock in a transaction dated Friday, April 28th. The stock was sold at an average price of $115.29, for a total value of $126,703.71. Following the sale, the director now directly owns 5,000 shares of the company’s stock, valued at approximately $576,450. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 13,030 shares of company stock valued at $1,581,964. 0.61% of the stock is owned by company insiders.

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

12 Month Chart for NASDAQ:CME

Receive News & Ratings for CME Group Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc and related companies with our FREE daily email newsletter.

 


Latest News

Zack Greinke Having Much Better Results This Season
Zack Greinke Having Much Better Results This Season
David Price and Red Sox to Meet Following Rehab Start
David Price and Red Sox to Meet Following Rehab Start
Lack of Offense Leading to Mediocrity for Boston Red Sox
Lack of Offense Leading to Mediocrity for Boston Red Sox
MLB and Facebook Announce Live Streaming for Games
MLB and Facebook Announce Live Streaming for Games
Can Anyway Stop the Houston Astros?
Can Anyway Stop the Houston Astros?
Kevin Pillar Turns from Defense to Offense
Kevin Pillar Turns from Defense to Offense


Leave a Reply

 
© 2006-2017 BBNS.